4Flamm MD, Harrison DC, Hancock EW. Muscular subaortic stenosis: prevention of outflow obstruction with propranolol [ J ]. Circulation,1968,38(5) :846-858.
5Maron BJ. Hypertrophic cardiomyopathy: a systematic review [J].JAMA,2002,287(10) : 1308-1320.
6Bonow RO, Dilsizian V, Rosing DR, et al. Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects[ J]. Circulation, 1985,72(9) : 853-864.
7Rick A, David R. Hypertrophic obstructive cardiomyopathy[ J]. N Engl J Med,2004,350(10) : 1320-1327.
8Schulte HD, Borisov K, Gams E, et al. Management of symptomatic hypertrophic obstructive cardiomyopathy-long-term results after surgical therapy[J] .Thorac Cardiovasc Surg, 1999,47(4):213-218.
9Maron BJ, Nishimura RA, McKenna WJ, et al. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy:a randomized, double-blind, crossover study ( M-PATHY ) [ J ]. Circulation, 1999, 99(6) : 2927-2933.
10Ommen SR, Nishimura RA, Squires RW, et al. Comparison of dualchamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy:a comparison of objective hemodynamic and exercise end points[J]. J Am Coll Cardiol, 1999,34(1):191-196.
